Inan Muharrem, Chan Gilbert, Bowen James Richard
Department of Orthopedics, AI. duPont Hospital for Children, Wilmington, Delaware 19899, USA.
J Pediatr Orthop B. 2008 Jan;17(1):43-6. doi: 10.1097/BPB.0b013e3282e61af7.
The aims of this study were to determine factors that cause a leg-length discrepancy (LLD) to the extent that correction is indicated after treatment in developmental dysplasia of the hip and determine whether the LLD may be treated with a percutaneous epiphysiodesis. Twelve children were included in this study. The factors which caused LLD were avascular necrosis, femoral shortening and varus at reduction, and septic arthritis. Percutaneous epiphysiodesis of the contralateral limb reduced the mean predicted LLD from 3.8 to 1.2 cm at maturity. We concluded that LLD (>2.5 cm) might result from complications of developmental dysplasia of the hip and these patients can be treated with a percutaneous epiphysiodesis.
本研究的目的是确定在发育性髋关节发育不良治疗后导致腿长差异(LLD)达到需要进行矫正程度的因素,并确定LLD是否可用经皮骨骺阻滞术治疗。本研究纳入了12名儿童。导致LLD的因素有股骨头缺血性坏死、复位时股骨缩短和内翻以及化脓性关节炎。对侧肢体的经皮骨骺阻滞术使成熟时平均预测的LLD从3.8厘米降至1.2厘米。我们得出结论,LLD(>2.5厘米)可能由发育性髋关节发育不良的并发症引起,这些患者可用经皮骨骺阻滞术治疗。